Congress mandates FDA limits on toxic metals in baby formula
S. 2371 — Safe Baby Formula Act of 2025 · Filed by Tom Cotton (R-AR) · 3 cosponsors · Introduced Jul 22, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill requires the FDA to study how arsenic, cadmium, mercury, and lead in infant formula affect infant health, and to set enforceable limits on these toxic metals in formula within 90 days. Ordinary parents and infants benefit by ensuring formula is safer and contamination is regulated; manufacturers must comply with new standards.
Why we flagged it
The bill's sole operative mechanism is to mandate federal regulation of toxic-metal contamination in infant formula—a straightforward consumer-safety measure with no hidden provisions or narrow beneficiaries.
What the text implies
- The 90-day rulemaking deadline is aggressive; HHS may face pressure to adopt interim enforcement action levels rather than full rulemaking, potentially creating weaker standards than formal maximum contamination levels.
- The bill does not specify enforcement mechanisms, penalties, or recall procedures; implementation details will be determined by HHS and may affect how quickly contaminated products are removed from shelves.
- Manufacturers may face retroactive compliance costs if existing formula batches exceed newly established limits, potentially triggering recalls and supply disruptions.
- The study requirement (1 year) lags the standard-setting requirement (90 days), meaning limits will be set before the health-impact study is complete—standards may need revision if the study reveals unexpected findings.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
Infants and parents gain direct protection from regulated toxic-metal contamination in a product consumed daily by vulnerable populations. The bill imposes compliance costs on manufacturers but creates a clear public-health benefit with no offsetting cost to citizens.
Who stands to gain
- infant formula manufacturers (compliance costs offset by market confidence and reduced liability ris
- testing laboratories (increased demand for contamination testing)
Named in the bill
Secretary of Health and Human Services, FDA, infant formula manufacturers, Federal Food, Drug, and Cosmetic Act
Where it stands
3 cosponsors: 3 Republicans.
- Jul 22, 2025 — Introduced · Congress.gov: “Introduced in Senate”
- Jul 22, 2025 — Referred to Senate Committee on Health, Education, Labor, and Pensions · Congress.gov: “Read twice and referred to the Committee on Health, Education, Labor, and Pensions”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (865 characters) on Aug 12, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
As of — page rendered 2026-10-20.
“Congress mandates FDA limits on toxic metals in baby formula” QuorumCivic. https://share.quorumcivic.app/bill/119/s2371 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.